ArticleMolecular cancer2024

Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells.

Chengwu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.